Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 30(15): 127279, 2020 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-32527459

RESUMEN

The synthesis and structure activity relationship development of a pyrimidine series of heterocyclic Factor IXa inhibitors is described. Increased selectivity over Factor Xa inhibition was achieved through SAR expansion of the P1 element. Select compounds were evaluated in vivo to assess their plasma levels in rat.


Asunto(s)
Descubrimiento de Drogas , Factor IXa/antagonistas & inhibidores , Inhibidores del Factor Xa/farmacología , Pirimidinas/farmacología , Relación Dosis-Respuesta a Droga , Factor IXa/metabolismo , Inhibidores del Factor Xa/síntesis química , Inhibidores del Factor Xa/química , Humanos , Estructura Molecular , Pirimidinas/síntesis química , Pirimidinas/química , Relación Estructura-Actividad
2.
Eur J Pharmacol ; 535(1-3): 182-91, 2006 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-16540104

RESUMEN

Melanin concentrating hormone (MCH) is a cyclic neuropeptide expressed in the lateral hypothalamus that plays an important role in energy homeostasis. To investigate the pharmacological consequences of inhibiting MCH signaling in murine obesity models, we examined the effect of acute and chronic administration of a selective MCH1 receptor antagonist (SCH-A) in diet-induced obese (DIO) and Lep(ob/ob) mice. Oral administration of SCH-A for 5 consecutive days (30 mg/kg q.d.) produced hypophagia, a loss of body weight and adiposity, and decreased plasma leptin levels in DIO mice, and hypophagia and reduced weight gain in Lep(ob/ob) mice. Chronic administration of SCH-A to DIO mice decreased food intake, body weight and adiposity, and plasma leptin and free fatty acids. These effects were accompanied by increases in several hypothalamic neuropeptides. Acute administration of SCH-A (30 mg/kg) prevented the decrease in energy expenditure associated with food restriction. These results indicate that MCH1 receptor antagonists may be effective in the treatment of obesity.


Asunto(s)
Ingestión de Alimentos/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Nitrilos/farmacología , Obesidad/fisiopatología , Piperazinas/farmacología , Receptores de Somatostatina/antagonistas & inhibidores , Urea/análogos & derivados , Tejido Adiposo/efectos de los fármacos , Administración Oral , Animales , Unión Competitiva , Peso Corporal/efectos de los fármacos , Encéfalo/metabolismo , Células CHO , Cricetinae , Cricetulus , Grasas de la Dieta/administración & dosificación , Relación Dosis-Respuesta a Droga , Ácidos Grasos no Esterificados/sangre , Femenino , Galanina/genética , Expresión Génica/efectos de los fármacos , Homeostasis/efectos de los fármacos , Hormonas Hipotalámicas/genética , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Insulina/sangre , Péptidos y Proteínas de Señalización Intracelular/genética , Radioisótopos de Yodo , Leptina/sangre , Masculino , Melaninas/genética , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Neuropéptido Y/genética , Neuropéptidos/genética , Nitrilos/administración & dosificación , Obesidad/etiología , Oligopéptidos/metabolismo , Receptores de Orexina , Orexinas , Piperazinas/administración & dosificación , Hormonas Hipofisarias/genética , Unión Proteica , Receptores Acoplados a Proteínas G , Receptores de Neuropéptido , Receptores de Somatostatina/genética , Receptores de Somatostatina/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Triglicéridos/sangre , Urea/administración & dosificación , Urea/farmacología
3.
Obes Res ; 12(8): 1327-34, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15340116

RESUMEN

OBJECTIVE: To identify and functionally characterize single-nucleotide polymorphisms (SNPs) in melanin-concentrating hormone (MCH)-R1 and -R2. RESEARCH METHODS AND PROCEDURES: The entire coding regions and intron/exon splice junction regions of MCH-R1 and MCH-R2 were sequenced from anonymous white (n=45) and African-American (n=46) individuals. DNA was analyzed, and SNPs were identified using Phred, Phrap, and Consed software. DNA constructs containing MCH-R1 and MCH-R2 SNPs were generated and expressed in CHO cells. The effect of the SNPs in MCH-R1 and MCH-R2 were assessed in receptor binding assays and functional assays measuring changes in intracellular cAMP and Ca2+ levels. RESULTS: We identified 12 SNPs in the MCH-R1 gene. Two of these SNPs are in coding regions, and one produces an arginine-for-glycine substitution at residue 34 in the MCH-R1 sequence. This SNP is present at a minor allele frequency of 15% in the African-American population tested in this study. We identified eight SNPs in the MCH-R2 gene. Four of these SNPs are in coding regions, and two produce amino acid substitutions. Lysine substitutes for arginine at residue 63 of the African-American population, and glutamine substitutes for arginine at residue 152 in whites (minor allele frequency of 2% for both SNPs). No changes in receptor binding or functional signaling were observed with the SNP mutations in MCH-R1 or MCH-R2. DISCUSSION: These data indicate that potential therapeutics designed to act at the MCH receptor are unlikely to have altered effects in subpopulations that express variant forms of MCH-R1 or MCH-R2.


Asunto(s)
Polimorfismo de Nucleótido Simple , Receptores de la Hormona Hipofisaria/genética , Receptores de Somatostatina/genética , Secuencia de Aminoácidos , Población Negra , Exones , Humanos , Hormonas Hipotalámicas/química , Hormonas Hipotalámicas/metabolismo , Intrones , Melaninas/química , Melaninas/metabolismo , Datos de Secuencia Molecular , Hormonas Hipofisarias/química , Hormonas Hipofisarias/metabolismo , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas/genética , Empalme del ARN , Receptores Acoplados a Proteínas G , Análisis de Secuencia de ADN , Población Blanca
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA